"10.1371_journal.pone.0061671","plos one","2013-05-08T00:00:00Z","Carolina Molt√≥-Puigmart√≠; Eug√®ne Jansen; Joachim Heinrich; Marie Standl; Ronald P Mensink; Jogchum Plat; John Penders; Monique Mommers; Gerard H Koppelman; Dirkje S Postma; Carel Thijs","Department of Epidemiology, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands; National Institute for Public Health and the Environment, Center for Health Protection, Bilthoven, The Netherlands; Helmholtz Zentrum M√ºnchen, German Research Center for Environmental Health, Institute of Epidemiology I, Neuherberg, Germany; Institute of Medical Informatics, Biometry and Epidemiology, University of Munich, Munich, Germany; Department of Human Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Medical Microbiology, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children‚Äôs Hospital, GRIAC Research Institute, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; Department of Pulmonary Medicine and Tuberculosis, GRIAC Research Institute, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands","Designed KOALA Study, follow-up, data collection, data cleaning: J. Penders MM CT. Conceived the study: CMP CT. Plasma lipid measurements: EJ. Designed DNA collection, DNA processing: GHK DSP. Genotyping: JH MS. Developed statistical analysis plan: CMP CT. Interpreted the findings: CMP CT. Revised the data analysis and interpreted of the data, critically revised the manuscript for intellectual content, and read and approved the final manuscript: CMP EJ JH MS RPM J. Plat J. Penders MM GHK DSP CT. Analyzed the data: CMP. Wrote the paper: CMP.","The authors have read the journal‚Äôs policy and have the following conflicts: The University of Groningen has received an unrestricted educational grant for research from AstraZeneca, Chiesi, GSK, performed by the group of Prof Postma. Travel to ERS and/or ATS has been partially funded to the University of Groiningen by AstraZeneca, Chiesi, GSK, Nycomed. Fees for consultancies were given to the University of Groningen by AZ, Boehringer Ingelheim, Chiesi, GSK, Nycomed and TEVA. In addition, the authors‚Äô confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Carolina Molt√≥-Puigmart√≠","CM√P√",11,TRUE,2,NA,1,1,TRUE,TRUE,TRUE,1,"8",FALSE
